Skip to main content
Erschienen in: Supportive Care in Cancer 12/2013

01.12.2013 | Original Article

Treatment regret and quality of life following radical prostatectomy

verfasst von: Chelsea G. Ratcliff, Lorenzo Cohen, Curtis A. Pettaway, Patricia A. Parker

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Negative physical functioning outcomes including incontinence and erectile dysfunction are relatively common following radical prostatectomy (RP) and are associated with treatment regret and compromised quality of life (QOL). The role that treatment regret may have in influencing the association between prostate-specific QOL (i.e., sexual, urinary, bowl functioning) and general QOL following RP has not been examined.

Method

This study examined the associations of treatment regret, general QOL (36-item Short Form Health Survey physical and mental health (MCS) composite scores), and prostate-specific QOL (Prostate Cancer QOL sexual, urinary, bowl functioning, and cancer worry subscales) in 95 men who underwent RP for prostate cancer.

Results

Multiple regression analyses indicated that poorer sexual and urinary functioning was associated with poorer MCS. Additionally, men with lower sexual and urinary functioning reported greater treatment regret. Treatment regret was also associated with lower MCS. Finally, treatment regret partially mediated the effects of both sexual and urinary functioning on MCS.

Conclusions

These findings suggest that regardless of a patient's prostate-specific QOL, reducing treatment regret may improve mental health following RP. Though there are limited options to alter patients' sexual or urinary functioning following RP, treatment regret may be a modifiable contributor to post-surgical adjustment and QOL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Group USCSW (2010) United States Cancer Statistics: 1999–2007 incidence and mortality web-based report. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta Group USCSW (2010) United States Cancer Statistics: 1999–2007 incidence and mortality web-based report. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
2.
Zurück zum Zitat Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, Epstein JI (2012) Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate 72:58–64PubMedCrossRef Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, Epstein JI (2012) Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate 72:58–64PubMedCrossRef
3.
Zurück zum Zitat Schroeck FR, Krupski TL, Sun L, Albala DM, Price MM, Polascik TJ, Robertson CN, Tewari AK, Moul JW (2008) Independent predictors for dissatisfaction with and regret of treatment choice after radical prostatectomy. J Urol 179(4 - supplement):109CrossRef Schroeck FR, Krupski TL, Sun L, Albala DM, Price MM, Polascik TJ, Robertson CN, Tewari AK, Moul JW (2008) Independent predictors for dissatisfaction with and regret of treatment choice after radical prostatectomy. J Urol 179(4 - supplement):109CrossRef
4.
Zurück zum Zitat Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson J-E, Norlen BJ et al (2002) Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347(11):790–796PubMedCrossRef Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson J-E, Norlen BJ et al (2002) Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347(11):790–796PubMedCrossRef
6.
Zurück zum Zitat Penson DF, Litwin MS (2003) Quality of life after treatment for prostate cancer. Curr Urol Rep 4:185–195PubMedCrossRef Penson DF, Litwin MS (2003) Quality of life after treatment for prostate cancer. Curr Urol Rep 4:185–195PubMedCrossRef
7.
Zurück zum Zitat Penson DF, Feng Z, Kuniyuki A et al (2003) General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the Prostate Cancer Outcomes Study. J Clin Oncol 21:1147–1154PubMedCrossRef Penson DF, Feng Z, Kuniyuki A et al (2003) General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the Prostate Cancer Outcomes Study. J Clin Oncol 21:1147–1154PubMedCrossRef
9.
Zurück zum Zitat Sebesta M, Cespedes RD, Luhman E, Optenberg S, Thompson IM (2002) Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study population. Urology 60(6):1055–1058PubMedCrossRef Sebesta M, Cespedes RD, Luhman E, Optenberg S, Thompson IM (2002) Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study population. Urology 60(6):1055–1058PubMedCrossRef
12.
Zurück zum Zitat Herr HW (1994) Quality of life of incontinent men after radical prostatectomy. J Urol 151(3):652–654PubMed Herr HW (1994) Quality of life of incontinent men after radical prostatectomy. J Urol 151(3):652–654PubMed
13.
Zurück zum Zitat Lin Y (2011) Treatment decision regret and related factors following radical prostatectomy. Cancer Nurs 34(5):417–422PubMedCrossRef Lin Y (2011) Treatment decision regret and related factors following radical prostatectomy. Cancer Nurs 34(5):417–422PubMedCrossRef
14.
Zurück zum Zitat Hu JC, Kwan L, Saigal CS, Litwin MS (2003) Regret in men treated for localized prostate cancer. J Urol 169(6):2279–2283PubMedCrossRef Hu JC, Kwan L, Saigal CS, Litwin MS (2003) Regret in men treated for localized prostate cancer. J Urol 169(6):2279–2283PubMedCrossRef
15.
Zurück zum Zitat Gilbar O, Hevroni A (2007) Counterfactuals, coping strategies and psychological distress among breast cancer patients. Anxiety Stress Coping Int J 20(4):383–392CrossRef Gilbar O, Hevroni A (2007) Counterfactuals, coping strategies and psychological distress among breast cancer patients. Anxiety Stress Coping Int J 20(4):383–392CrossRef
16.
Zurück zum Zitat Clark JA, Wray NP, Ashton CM (2001) Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 19(1):72–80PubMed Clark JA, Wray NP, Ashton CM (2001) Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 19(1):72–80PubMed
17.
Zurück zum Zitat Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, Wei Q, Carr DD, Cohen L (2009) The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 27(19):3169–3176PubMedCrossRef Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, Wei Q, Carr DD, Cohen L (2009) The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 27(19):3169–3176PubMedCrossRef
18.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12(3):189–198CrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12(3):189–198CrossRef
19.
Zurück zum Zitat Cohen L, Parker PA, Vence L, Savary C, Kentor D et al (2011) Presurgical stress management improves post-operative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med 73(3):218–225PubMedCrossRef Cohen L, Parker PA, Vence L, Savary C, Kentor D et al (2011) Presurgical stress management improves post-operative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med 73(3):218–225PubMedCrossRef
20.
Zurück zum Zitat Ware J, Sherbourne C (1992) The MOS 36-item short form health survey. Med Care 30 Ware J, Sherbourne C (1992) The MOS 36-item short form health survey. Med Care 30
21.
Zurück zum Zitat Giesler R, Miles B, Cowen M, Kattan M (2000) Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res 9(6):645–665. doi:10.1023/a:1008931703884 PubMedCrossRef Giesler R, Miles B, Cowen M, Kattan M (2000) Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res 9(6):645–665. doi:10.​1023/​a:​1008931703884 PubMedCrossRef
22.
Zurück zum Zitat Baron RM, Kenny DA (1986) The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Personal Soc Psychol 51(6):1173–1182CrossRef Baron RM, Kenny DA (1986) The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Personal Soc Psychol 51(6):1173–1182CrossRef
23.
Zurück zum Zitat Cohen S, Mermelstein R, Kamarck T, Hoberman H (1985) Measuring the functional components of social support. Social support: theory, research, and applications. Martinus Nijhoff, The Hague Cohen S, Mermelstein R, Kamarck T, Hoberman H (1985) Measuring the functional components of social support. Social support: theory, research, and applications. Martinus Nijhoff, The Hague
24.
Zurück zum Zitat Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMedCrossRef Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMedCrossRef
26.
Zurück zum Zitat Parker PA, Middleton MS, Kulik JA (2002) Counterfactual thinking and quality of life among women with silicone breast implants. J Behav Med 25(4):317–335PubMedCrossRef Parker PA, Middleton MS, Kulik JA (2002) Counterfactual thinking and quality of life among women with silicone breast implants. J Behav Med 25(4):317–335PubMedCrossRef
27.
Zurück zum Zitat Davis C, Lehman D, Wortman C, Silver R, Thompson S (1995) The undoing of traumatic life events. Personal Soc Psychol Bull 21:109–124CrossRef Davis C, Lehman D, Wortman C, Silver R, Thompson S (1995) The undoing of traumatic life events. Personal Soc Psychol Bull 21:109–124CrossRef
28.
Zurück zum Zitat Mishel MH, Germino BB, Lin L, Pruthi RS, Wallen EM, Crandell J, Blyler D (2009) Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns 77(3):349–359PubMedCrossRef Mishel MH, Germino BB, Lin L, Pruthi RS, Wallen EM, Crandell J, Blyler D (2009) Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns 77(3):349–359PubMedCrossRef
29.
Zurück zum Zitat Kinsella J, Acher P, Ashfield A, Chatterton K, Dasgupta P, Cahill D, Popert R, O'Brien T (2012) Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study. Br J Urol Int 109(2):254–258CrossRef Kinsella J, Acher P, Ashfield A, Chatterton K, Dasgupta P, Cahill D, Popert R, O'Brien T (2012) Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study. Br J Urol Int 109(2):254–258CrossRef
30.
Zurück zum Zitat Goh AC, Kowalkowski MA, Bailey JDE, Kazer MW, Knight SJ, Latini DM (2011) Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. Br J Urol Int. doi:10.1111/j.1464-410X.2011.10791.x Goh AC, Kowalkowski MA, Bailey JDE, Kazer MW, Knight SJ, Latini DM (2011) Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. Br J Urol Int. doi:10.​1111/​j.​1464-410X.​2011.​10791.​x
31.
Zurück zum Zitat Schover LR, Canada AL, Yuan Y, Sui D, Neese L, Jenkins R, Rhodes MM (2012) A randomized trial of internet–based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 118(2):500–509. doi:10.1002/cncr.26308 PubMedCrossRef Schover LR, Canada AL, Yuan Y, Sui D, Neese L, Jenkins R, Rhodes MM (2012) A randomized trial of internet–based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 118(2):500–509. doi:10.​1002/​cncr.​26308 PubMedCrossRef
Metadaten
Titel
Treatment regret and quality of life following radical prostatectomy
verfasst von
Chelsea G. Ratcliff
Lorenzo Cohen
Curtis A. Pettaway
Patricia A. Parker
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1906-4

Weitere Artikel der Ausgabe 12/2013

Supportive Care in Cancer 12/2013 Zur Ausgabe

Letter to the editor

Reply to Molassiotis

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.